✦ LIBER ✦

PMH21 COST-EFFECTIVENESS OF OLANZAPINE LONG-ACTING INJECTION IN THE TREATMENT OF NON-ADHERENCE PATIENTS WITH SCHIZOPHRENIA IN THE UNITED STATES

✍ Scribed by H Ascher-Svanum; NM Furiak; RW Klein; W Montgomery; LJ Smolen; AH Lawson; RR Conley

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PMH42 COST-EFFECTIVENESS ANALYSIS OF OLA

✍ SM Carroll; N Jemiai; B Suter; P O'Donohoe; U Skjoldborg; J Moller; OK Kleivenes 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB

PMH31 Cost-Effectiveness of Long-Acting

✍ T. Dilla; P. O'Donohoe; J. Möller; M. Álvarez; J. Sacristán; L. San; M. Happich; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

PMH34 Long-Term Cost-Effectiveness of At

✍ K. Rajagopalan; K. O'Day; K. Meyer; A.A. Pikalov iii; A. Loebel 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

PMH42 Cost-Utility Analysis of Paliperid

✍ B.R.M. Kim; T.J. Lee; J.M. Woo; J.I. Park; J.S. Kwon 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

PMH48 VALIDATING A COST-EFFECTIVENESS AN

✍ C Graham; J Mauskopf; AH Lawson; H Ascher-Svanum; D Bruhn; PR Watson 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

PMH23 A Cost-Effectiveness Analysis of t

✍ T.R. Einarson; H. Pudas; R. Zilbershtein; R. Jensen; A.T. Nielsen; C. Piwko; M. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB